MedTrace Logo

Adding Contingency Management to Treatment as Usual for Disordered Gambling.

NCT02613754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2023-08-07

No results posted yet for this study

Summary

The aim of this study is to conduct a trial to investigate the efficacy of adding Contingency Management (CM) to Treatment as Usual (TAU) for the treatment of Disordered Gambling. Results from this experiment will provide the first evidence of the additional efficacy of best-practice CM and whether it can be easily integrated into a clinical environment. Additionally, this study will correlate clinical outcomes with psychological measures and participant responses to develop new predictive treatment outcome measures.

Conditions

  • Gambling, Pathological

Interventions

BEHAVIORAL

Contingency Management

See arm description.

BEHAVIORAL

Treatment as Usual

See arm description

Sponsors & Collaborators

  • Alberta Innovates Health Solutions

    collaborator OTHER

  • Alberta Gambling Research Institute

    collaborator UNKNOWN

  • University of Lethbridge

    lead OTHER

Principal Investigators

  • Darren R Christensen, PhD · University of Lethbridge

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2023-08-02
Completion
2023-08-02

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02613754 on ClinicalTrials.gov